205445-53-0

Basic information

• Product Name: BOC-D-3,5-DIFLUOROPHE
• Synonyms: N-BOC-3,5-DIFLUORO-D-PHENYLALANINE;Boc-D-3,5-Difluoro-phe-OH;N-Boc-D-Phe(3,5-F2)-OH;REF DUPL: N-Boc-D-Phe(3,5-F2)-OH;￡¨R￡-N-Boc-3,5-Difluorophenylalanine;Boc-D-Phe(3,5-F2)-OH Boc-3,5-Difluoro-D-Phenylalanine;N-Boc-D-3,5-difluorophenylalanine;(R)-3-(3,5-difluorophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
• CAS NO: 205445-53-0
• Molecular Formula: C₁₄H₁₇F₂NO₄
• Molecular Weight: 301.29
• Product Categories: Phenylalanine analogs and other aromatic alpha amino acids;Peptide;Amino Acids
• Mol File: 205445-53-0.mol

Chemical Properties

• Boiling Point: 417.6 °C at 760 mmHg
• Flash Point: 206.4 °C
• Appearance: /
• Density: 1.27 g/cm³
• Vapor Pressure: 1.01E-07mmHg at 25°C
• Refractive Index: 1.506
• Storage Temp.: Store at 0°C
• CAS DataBase Reference: BOC-D-3,5-DIFLUOROPHE(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-D-3,5-DIFLUOROPHE(205445-53-0)
• EPA Substance Registry System: BOC-D-3,5-DIFLUOROPHE(205445-53-0)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 205445-53-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
BOC-D-3,5-DIFLUOROPHE is used as a building block for the synthesis of pharmaceutical compounds, contributing to the development of new therapeutic agents.
Used in Drug Design:
BOC-D-3,5-DIFLUOROPHE is utilized in the study of structure-activity relationships, aiding in the optimization of drug candidates for enhanced efficacy and safety.
Used in Medicinal Chemistry:
BOC-D-3,5-DIFLUOROPHE is employed as a key component in the synthesis of various pharmaceutical compounds, facilitating the discovery of novel therapeutic agents.
Used in Drug Candidate Development:
BOC-D-3,5-DIFLUOROPHE is used as a starting material in the development of new drug candidates, enabling researchers to explore its potential in treating various diseases and conditions.
Used in Chemical and Biological Research:
BOC-D-3,5-DIFLUOROPHE is valued for its stability and compatibility with standard laboratory procedures, making it a versatile tool for researchers in chemical and biological studies.

InChI:InChI=1/C14H17F2NO4/c1-14(2,3)21-13(20)17-11(12(18)19)6-8-4-9(15)7-10(16)5-8/h4-5,7,11H,6H2,1-3H3,(H,17,20)(H,18,19)/t11-/m1/s1

Upstream product

• 1246400-77-0 (R)-methyl 2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate 

Downstream Products

• 1416468-41-1 (4aS,8aR)-2-{1-[(2R)-2-amino-3-(3,5-difluorophenyl)propanoyl]piperidin-4-yl}-4-(3,4-dimethoxyphenyl)-4a,5,6,7,8,8a-hexahydrophthalazin-1(2H)-one 
• 1416467-05-4 4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(2R)-3-(3,5-difluorophenyl)-1-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-1-oxopropan-2-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide 
• 1416468-72-8 tert-butyl [(2R)-3-(3,5-difluorophenyl)-1-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,6,7,8,8a-hexahydrophthalazin-2(1H)-yl]piperidin-1-yl}-1-oxopropan-2-yl]carbamate 

Relevant articles and documents

Discovery of pyrrolopyrimidine inhibitors of Akt

The discovery and optimization of a series of pyrrolopyrimidine based protein kinase B (Pkb/Akt) inhibitors discovered via HTS and structure based drug design is reported. The compounds demonstrate potent inhibition of all three Akt isoforms and knockdown of phospho-PRAS40 levels in LNCaP cells and tumor xenografts.

Highly modular P-OP ligands for asymmetric hydrogenation: Synthesis, catalytic activity, and mechanism

A library of enantiomerically pure P-OP ligands (phosphine-phosphite), straightforwardly available in two synthetic steps from enantiopure Sharpless epoxy ethers is reported. Both the alkyloxy and phosphite groups can be optimized for maximum enantioselectivity and catalytic activity. Their excellent performance in the Rhcatalyzed asymmetric hydrogenation of a wide variety of functionalized alkenes (26 examples) and modular design makes them attractive for future applications. The lead catalyst incorporates an (S)-BINOL-derived (BINOL= 1,1'bi-2-naphthol) phosphite group with computational studies revealing that this moiety has a dual effect on the behavior of our P-OP ligands. On one hand, the electronic properties of phosphite hinder the binding and reaction of the substrate in two out of the four possible manifolds. On the other hand, the steric effects of the BINOL allow for discrimination between the two remaining manifolds, thereby elucidating the high efficiency of these catalysts.